Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Bicycletx Limited

Clinical trials sponsored by Bicycletx Limited, explained in plain language.

BicycleTx Limited BCYC NASDAQ

Biopharmaceutical company developing bicyclic peptide-based therapeutics.

Trade on eToro (ad)

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Trials to join now! 1 Not yet recruiting 1 Not yet finished but already full! 6

New drug targets tough pancreatic cancer in early trial

Disease control Recruiting now

This phase 2 study tests an experimental drug called BT5528 in adults with metastatic pancreatic cancer that has spread and worsened after one prior treatment. The drug targets a specific protein on cancer cells. Researchers will measure how well it shrinks tumors and track side …

Phase: PHASE2 • Sponsor: BicycleTx Limited • Aim: Disease control

Last updated Aug 15, 2026 00:00 UTC